We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+40.76%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$1.73B
AUM Growth
+$486M
Cap. Flow
+$57.8M
Cap. Flow %
3.35%
Top 10 Hldgs %
31.64%
Holding
230
New
36
Increased
82
Reduced
35
Closed
4

Top Sells

Rank Stock Value
1
WW
WW International
WW
+$15.6M
2
IRM icon
Iron Mountain
IRM
+$11M
3
SCHW
Charles Schwab
SCHW
+$8.89M
4
DXCM icon
DexCom
DXCM
+$3.46M
5
ABMD
Abiomed Inc
ABMD
+$3.02M

Sector Composition

Rank Sector Weight
1 Healthcare 25.44%
2 Technology 19.91%
3 Financials 19.27%
4 Communication Services 9.98%
5 Consumer Discretionary 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
26
Idexx Laboratories
IDXX
$44.1B
$29.9M 1.74%
90,709
-270
-0.3% -$78.2K
CVNA icon
27
Carvana
CVNA
$68.6B
$29.3M 1.7%
1,219,860
-9,150
-0.7% -$171K
WDAY icon
28
Workday
WDAY
$39.6B
$28.4M 1.65%
151,620
+1,508
+1% +$244K
TRU icon
29
TransUnion
TRU
$15.1B
$24.9M 1.44%
285,995
+4,799
+2% +$383K
EW icon
30
Edwards Lifesciences
EW
$49.6B
$24M 1.39%
347,774
+3,992
+1% +$284K
MSFT icon
31
Microsoft
MSFT
$3.45T
$21.9M 1.27%
107,576
+5,109
+5% +$927K
FAST icon
32
Fastenal
FAST
$54.7B
$21.8M 1.26%
1,017,746
-35,920
-3% -$687K
GH icon
33
Guardant Health
GH
$21.7B
$20.3M 1.18%
250,778
+48,443
+24% +$3.9M
QNST icon
34
QuinStreet
QNST
$890M
$20.2M 1.17%
1,935,768
-75,002
-4% -$724K
PINS icon
35
Pinterest
PINS
$13.4B
$20.2M 1.17%
909,741
-108,918
-11% -$2.13M
MORN icon
36
Morningstar
MORN
$7.22B
$20.1M 1.17%
142,615
-482
-0.3% -$68K
EXEL icon
37
Exelixis
EXEL
$13.3B
$19.6M 1.13%
823,925
+18,363
+2% +$426K
SHOP icon
38
Shopify
SHOP
$152B
$14.4M 0.83%
+151,200
New +$10.5M
XOM icon
39
ExxonMobil
XOM
$644B
$14.3M 0.83%
319,448
-878
-0.3% -$39.4K
ALBO
40
DELISTED
Albireo Pharma Inc
ALBO
$13.3M 0.77%
502,212
+9,334
+2% +$220K
TSM icon
41
TSMC
TSM
$2.1T
$12.1M 0.7%
213,158
-2,418
-1% -$127K
AXDX
42
DELISTED
Accelerate Diagnostics
AXDX
$11.5M 0.66%
75,548
-14,228
-16% -$1.4M
ABMD
43
DELISTED
Abiomed Inc
ABMD
$11.4M 0.66%
47,198
-15,054
-24% -$3.02M
MA icon
44
Mastercard
MA
$502B
$10.5M 0.61%
35,634
+3,456
+11% +$974K
JNJ icon
45
Johnson & Johnson
JNJ
$618B
$9.44M 0.55%
67,150
+1,366
+2% +$199K
ZBRA icon
46
Zebra Technologies
ZBRA
$14B
$9.11M 0.53%
35,606
-100
-0.3% -$23.4K
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.1T
$8.64M 0.5%
48,429
-2,498
-5% -$456K
GPN icon
48
Global Payments
GPN
$23B
$7.18M 0.42%
42,349
PEP icon
49
PepsiCo
PEP
$190B
$5.68M 0.33%
42,979
+3,548
+9% +$468K
JPM icon
50
JPMorgan Chase
JPM
$935B
$5.67M 0.33%
60,229
+100
+0.2% +$9.49K

Similar funds

Chicago Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Chicago Capital held 230 positions worth $1.73B, up 39% from $1.24B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Chicago Capital deployed $57.8M of net new capital in Q2 2020, opening 36 new positions and adding to 82 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 430,824 shares worth $30.1M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was WW International, an estimated $15.6M trimmed.

  • Chicago Capital's largest Q2 2020 buy was Ligand Pharmaceuticals: 430,824 shares worth $30.1M.
  • Chicago Capital added most to SVB Financial Group in Q2 2020, an estimated $12.4M increase.
  • Chicago Capital's biggest Q2 2020 reduction was WW International, cutting an estimated $15.6M.
  • Chicago Capital fully exited Royal Dutch Shell PLC ADS Class A in Q2 2020, selling an estimated $276K.
  • Chicago Capital's ten largest holdings make up 32% of its $1.73B portfolio in Q2 2020.
  • Chicago Capital opened 36 new positions and closed 4 in Q2 2020.
  • Chicago Capital's portfolio value rose 39% quarter-over-quarter to $1.73B.

Based on Chicago Capital's 13F filing for Q2 2020, filed 29 Jul 2020.